Evaluation of Flexible Tacrolimus Drug Concentration Monitoring Approach in Patients Receiving Extended‐Release Once‐Daily Tacrolimus Tablets

The majority of United States kidney transplant patients are treated with tacrolimus, a drug effective in preventing graft rejection, but with a narrow therapeutic range, necessitating close monitoring to avoid increased risks of transplant rejection or toxicity if the tacrolimus concentration is to...

Descripción completa

Detalles Bibliográficos
Autores principales: Philosophe, Benjamin, Leca, Nicolae, West‐Thielke, Patricia M., Horwedel, Timothy, Culkin‐Gemmell, Christine, Kistler, Kristin, Stevens, Daniel R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Therapeutic Drug Monitoring
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032903/
https://www.ncbi.nlm.nih.gov/pubmed/29462506
http://dx.doi.org/10.1002/jcph.1082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032903/
https://www.ncbi.nlm.nih.gov/pubmed/29462506
http://dx.doi.org/10.1002/jcph.1082

Ejemplares similares